LegoChem Biosciences Inc (141080) - Total Liabilities

Latest as of March 2026: ₩152.41 Billion KRW ≈ $103.29 Million USD

Based on the latest financial reports, LegoChem Biosciences Inc (141080) has total liabilities worth ₩152.41 Billion KRW (≈ $103.29 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of LegoChem Biosciences Inc to see how much of total assets are deployed in long-term investments.

LegoChem Biosciences Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how LegoChem Biosciences Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 141080 total assets.

LegoChem Biosciences Inc Competitors by Total Liabilities

The table below lists competitors of LegoChem Biosciences Inc ranked by their total liabilities.

Company	Country	Total Liabilities
China Meheco Co Ltd SHG:600056	China	CN¥22.88 Billion
AVI LTD (UNSP.ADR)/5 F:IZ60	Germany	€4.53 Billion
Tung Ho Steel Enterprise Corp TW:2006	Taiwan	NT$19.09 Billion
Polaris Bay Group Co Ltd SHG:600155	China	CN¥49.24 Billion
Wasu Media Holding Co Ltd SHE:000156	China	CN¥14.28 Billion
Pfizer Limited NSE:PFIZER	India	Rs-42.03 Billion
Inno Laser Technology Co. Ltd. SHE:301021	China	CN¥184.04 Million
Anywhere Real Estate Inc NYSE:HOUS	USA	$4.22 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down LegoChem Biosciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 141080 net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	10.12	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.33	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.23	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how LegoChem Biosciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for LegoChem Biosciences Inc (2014–2025)

The table below shows the annual total liabilities of LegoChem Biosciences Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩160.69 Billion ≈ $108.90 Million	+31.30%
2024-12-31	₩122.38 Billion ≈ $82.94 Million	+196.47%
2023-12-31	₩41.28 Billion ≈ $27.98 Million	+25.35%
2022-12-31	₩32.93 Billion ≈ $22.32 Million	-4.43%
2021-12-31	₩34.46 Billion ≈ $23.35 Million	+44.87%
2020-12-31	₩23.79 Billion ≈ $16.12 Million	-14.22%
2019-12-31	₩27.73 Billion ≈ $18.79 Million	+38.49%
2018-12-31	₩20.02 Billion ≈ $13.57 Million	-41.17%
2017-12-31	₩34.03 Billion ≈ $23.06 Million	+15.40%
2016-12-31	₩29.49 Billion ≈ $19.99 Million	+16.74%
2015-12-31	₩25.26 Billion ≈ $17.12 Million	+84.24%
2014-12-31	₩13.71 Billion ≈ $9.29 Million	--

About LegoChem Biosciences Inc

KQ:141080 Korea Biotechnology

Market Cap

$1.98 Billion

₩2.92 Trillion KRW

Market Cap Rank

#6263 Global

#147 in Korea

Share Price

₩80200.00

Change (1 day)

-2.08%

52-Week Range

₩77900.00 - ₩213500.00

All Time High

₩213500.00